0001209191-19-013589.txt : 20190226 0001209191-19-013589.hdr.sgml : 20190226 20190226165125 ACCESSION NUMBER: 0001209191-19-013589 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190222 FILED AS OF DATE: 20190226 DATE AS OF CHANGE: 20190226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FUCHS HENRY J CENTRAL INDEX KEY: 0001197355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 19634170 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-22 0 0001131324 GENOMIC HEALTH INC GHDX 0001197355 FUCHS HENRY J BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 1 0 0 0 Common Stock 2019-02-22 4 M 0 20000 33.67 A 26332 D Common Stock 2019-02-22 4 M 0 6479 27.75 A 32811 D Common Stock 2019-02-22 4 S 0 11479 82.1127 D 21332 D Common Stock 2019-02-22 4 S 0 14490 81.7037 D 6842 D Common Stock 2019-02-22 4 S 0 510 82.2454 D 6332 D Common Stock 2019-02-25 4 M 0 3521 27.75 A 9853 D Common Stock 2019-02-25 4 S 0 3000 78.8833 D 6853 D Common Stock 2019-02-25 4 S 0 521 79.8014 D 6332 D Director Stock Option (right to buy) 33.67 2019-02-22 4 M 0 20000 0.00 D 2023-09-17 Common Stock 20000 0 D Director Stock Option (right to buy) 27.75 2019-02-22 4 M 0 6479 0.00 D 2015-06-06 2024-06-06 Common Stock 6479 3521 D Director Stock Option (right to buy) 27.75 2019-02-25 4 M 0 3521 0.00 D 2015-06-06 2024-06-06 Common Stock 3521 0 D Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $82.00 to $82.34. Represents weighted average sale price. Actual sale prices ranged from $81.21 to $82.20. Represents weighted average sale price. Actual sale prices ranged from $82.21 to $82.2538. Represents weighted average sale price. Actual sale prices ranged from $78.50 to $79.17. Represents weighted average sale price. Actual sale prices ranged from $79.54 to $80.02. The option became exercisable as to 25% of the shares on September 17, 2014, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2019-02-26